Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Nurix Therapeutics (NRIX) Tax Provisions: 2019-2025

Historic Tax Provisions for Nurix Therapeutics (NRIX) over the last 3 years, with May 2025 value amounting to $760,000.

  • Nurix Therapeutics' Tax Provisions rose 744.44% to $760,000 in Q2 2025 from the same period last year, while for May 2025 it was $940,000, marking a year-over-year increase of 968.18%. This contributed to the annual value of $270,000 for FY2024, which is N/A change from last year.
  • Latest data reveals that Nurix Therapeutics reported Tax Provisions of $760,000 as of Q2 2025, which was up 9,400.00% from $8,000 recorded in Q4 2024.
  • In the past 5 years, Nurix Therapeutics' Tax Provisions ranged from a high of $760,000 in Q2 2025 and a low of -$123,000 during Q3 2021.
  • Its 2-year average for Tax Provisions is $206,000, with a median of $90,000 in 2024.
  • Data for Nurix Therapeutics' Tax Provisions shows a peak YoY spiked of 744.44% (in 2025) over the last 5 years.
  • Over the past 3 years, Nurix Therapeutics' Tax Provisions (Quarterly) stood at $31,000 in 2021, then reached $8,000 in 2024, then spiked by 744.44% to $760,000 in 2025.
  • Its last three reported values are $760,000 in Q2 2025, $8,000 for Q4 2024, and $82,000 during Q3 2024.